Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
Wpływosimózgowo-jelitowejnastanzdrowiapsychicznego
65
MadanA.,TompsonD.,FowlerJ.C.,AjamiN.J.,SalasR.,FruehB.C.,BradshawM.R.,Weinste-
inB.L.,OldhamJ.M.,PetrosinoJ.F.,Tegutmicrobiotaisassociatedwithpsychiatricsymp-
tomseverityandtreatmentoutcomeamongindividualswithseriousmentalillness,,,JAfect
Disord”2020,nr264.
MaesM.,LeunisJ.C.,Normalizationofleakygutinchronicfatiguesyndrome(CFS)isaccompa-
niedbyaclinicalimprovement:electsofage,durationofillnessandthetranslocationofLPS
fromgram-negativebacteria,,,NeuroEndocrinolLett”2008,nr29(6).
MalhiG.S.,MannJ.J.,Depression,,,Lancet”2018,nr392(10161).
MasatoA.,PlotegherN.,BoassaD.,BubaccoL.,ImpaireddopaminemetabolisminParkinson’s
diseasepathogenesis,,,MolNeurodegener”2019,nr14(1).
MessaoudiM.,LalondeR.,ViolleN.,JavelotH.,DesorD.,NejdiA.,BissonJ.F.,RougeotC.,Pi-
chelinM.,CazaubielM.,CazaubielJ.M.,Assessmentofpsychotropic-likepropertiesofapro-
bioticformulation(LactobacillushelveticusR0052andBifdobacteriumlongumR0175)inrats
andhumansubjects,,,BrJNutr”2011,nr105(5).
MessaoudiM.,ViolleN.,BissonJ.F.,DesorD.,JavelotH.,RougeotC.,Benefcialpsychologicalef-
fectsofaprobioticformulation(LactobacillushelveticusR0052andBifdobacteriumlongum
R0175)inhealthyhumanvolunteers,,,GutMicrobes”2011,nr2(4).
MichelL.,PratA.,Onemoreroleforthegut:microbiotaandbloodbrainbarrier,,,AnnTransl
Med”2016,nr4(1).
NaseribafroueiA.,HestadK.,AvershinaE.,SekeljaM.,LinløkkenA.,WilsonR.,RudiK.,Corre-
lationbetweenthehumanfecalmicrobiotaanddepression,,,NeurogastroenterolMotil”2014,
nr26(8).
NeumannI.D.,WegenerG.,HombergJ.R.,CohenH.,SlatteryD.A.,ZoharJ.,OlivierJ.D.A.,Mathé
A.A.,Animalmodelsofdepressionandanxiety:Whatdotheytellusabouthumancondition?,
,,ProgNeuropsychopharmacolBiolPsychiatry”2011,nr35(6).
O’MahonyS.M.,HylandN.P.,DinanT.G.,CryanJ.F.,Maternalseparationasamodelofbrain-
-gutaxisdysfunction,,,Psychopharmacology(Berl)”2011,nr214(1).
PascaleA.,MarchesiN.,GovoniS.,BarbieriA.,Targetingthemicrobiotainpharmacologyofpsy-
chiatricdisorders,,,PharmacolRes”2020,nr157.
ReardonS.,Gut-brainlinkgrabsneuroscientists,,,Nature”2014,nr515(7526).
RinninellaE.,RaoulP.,CintoniM.,FranceschiF.,MiggianoG.A.D.,GasbarriniA.,MeleM.C.,
WhatistheHealthyGutMicrobiotaComposition?AChangingEcosystemacrossAge,Envi-
ronment,Diet,andDiseases,,,Microorganisms”2019,nr7(1).
SbahiH.,DiPalmaJ.A.,Faecalmicrobiotatransplantation:applicationsandlimitationsintrea-
tinggastrointestinaldisorders,,,BMJOpenGastroenterol”2016,nr3(1).
SchwarzE.,MaukonenJ.,HyytiäinenT.,KieseppäT.,OrešičM.,SabunciyanS.,MantereO.,Saarela
M.,YolkenR.,SuvisaariJ.,Analysisofmicrobiotainfrstepisodepsychosisidentifesprelimina-
ryassociationswithsymptomseverityandtreatmentresponse,,,SchizophrRes”2018,nr192.
ShenY.,XuJ.,LiZ.,HuangY.,YuanY.,WangJ.,ZhangM.,HuS.,LiangY.,Analysisofgutmicro-
biotadiversityandauxiliarydiagnosisasabiomarkerinpatientswithschizophrenia:Across-
-sectionalstudy,,,SchizophrRes”2018,nr197.
StillingR.M.,DinanT.G.,CryanJ.F.,Microbialgenes,brain&behaviour-epigeneticregulation
ofthegut-brainaxis,,,GenesBrainBehavior”2014,nr13(1).
SungH.Y.,ParkJ.W.,KimJ.S.,Tefrequencyandseverityofgastrointestinalsymptomsinpatients
withearlyParkinson’sdisease,,,JMovDisord”2014,nr7(1).
TamtajiO.R.,TaghizadehM.,KakhakiR.D.,KouchakiE.,BahmaniF.,BorzabadiS.,OryanS.,
MafiA.,AsemiZ.,Clinicalandmetabolicresponsetoprobioticadministrationinpeoplewith
Parkinson’sdisease:Arandomized,double-blind,placebo-controlledtrial,,,ClinNutr”2019,
nr38(3).
